Protective Effect of Blepharospasm on the Anterior Segment of the Eye

Acta Clin Croat. 2018 Mar;57(1):130-133. doi: 10.20471/acc.2018.57.01.16.

Abstract

The aim of the study was to determine the role of blepharospasm as a protective factor for the anterior segment of the eye by comparing the degree of blepharospasm and changes of the anterior segment structures. The study included sixty female patients older than forty years with the clinical diagnosis of blepharospasm. They were divided into two groups; the first group consisted of patients with stage I and II of blepharospasm with dominant dry eye symptoms, and the second group consisted of patients with stage III and IV of blepharospasm who required interventional therapy (all patients in this study were treated with botulinum toxin type A). Staining of ocular surface with vital dyes such as fluorescein was used to determine ocular surface defects. Fluorescein stains the corneal epithelial defects, which were statistically less pronounced in the interventional group. In conclusion, comparison of the results between the two groups of patients may implicate that advanced blepharospasm has a protective effect on ocular surface.

Keywords: Blepharospasm; Dry eye syndrome; Fluorescein; Protective factors; Staining and labeling.

MeSH terms

  • Adult
  • Blepharospasm*
  • Botulinum Toxins, Type A
  • Dry Eye Syndromes* / prevention & control
  • Female
  • Humans
  • Neuromuscular Agents*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A